These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 28722471)

  • 1. Simulated annealing molecular dynamics and ligand-receptor contacts analysis for pharmacophore modeling.
    Hatmal MM; Taha MO
    Future Med Chem; 2017 Jul; 9(11):1141-1159. PubMed ID: 28722471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combining molecular dynamics simulation and ligand-receptor contacts analysis as a new approach for pharmacophore modeling: beta-secretase 1 and check point kinase 1 as case studies.
    Hatmal MM; Jaber S; Taha MO
    J Comput Aided Mol Des; 2016 Dec; 30(12):1149-1163. PubMed ID: 27722817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combining Stochastic Deformation/Relaxation and Intermolecular Contacts Analysis for Extracting Pharmacophores from Ligand-Receptor Complexes.
    Hatmal MM; Taha MO
    J Chem Inf Model; 2018 Apr; 58(4):879-893. PubMed ID: 29529367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dynamic structure based pharmacophore modeling of the Acetylcholinesterase reveals several potential inhibitors.
    Shiri F; Pirhadi S; Ghasemi JB
    J Biomol Struct Dyn; 2019 Apr; 37(7):1800-1812. PubMed ID: 29695192
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of new JNK3 inhibitory chemotypes via QSAR-Guided selection of docking-based pharmacophores and comparison with other structure-based pharmacophore modeling methods.
    Tuffaha GO; Hatmal MM; Taha MO
    J Mol Graph Model; 2019 Sep; 91():30-51. PubMed ID: 31158642
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery of nanomolar phosphoinositide 3-kinase gamma (PI3Kγ) inhibitors using ligand-based modeling and virtual screening followed by in vitro analysis.
    Taha MO; Al-Sha'er MA; Khanfar MA; Al-Nadaf AH
    Eur J Med Chem; 2014 Sep; 84():454-65. PubMed ID: 25050878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of novel acetylcholinesterase inhibitors through e-pharmacophore-based virtual screening and molecular dynamics simulations.
    Malik R; Choudhary BS; Srivastava S; Mehta P; Sharma M
    J Biomol Struct Dyn; 2017 Nov; 35(15):3268-3284. PubMed ID: 27782777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantifying ligand-receptor interactions for gorge-spanning acetylcholinesterase inhibitors for the treatment of Alzheimer's disease.
    Martis EA; Chandarana RC; Shaikh MS; Ambre PK; D'Souza JS; Iyer KR; Coutinho EC; Nandan SR; Pissurlenkar RR
    J Biomol Struct Dyn; 2015; 33(5):1107-25. PubMed ID: 24905476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of molecular descriptors for design of novel Isoalloxazine derivatives as potential Acetylcholinesterase inhibitors against Alzheimer's disease.
    Gurung AB; Aguan K; Mitra S; Bhattacharjee A
    J Biomol Struct Dyn; 2017 Jun; 35(8):1729-1742. PubMed ID: 27410776
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, synthesis, biological properties, and molecular modeling investigations of novel tacrine derivatives with a combination of acetylcholinesterase inhibition and cannabinoid CB1 receptor antagonism.
    Lange JH; Coolen HK; van der Neut MA; Borst AJ; Stork B; Verveer PC; Kruse CG
    J Med Chem; 2010 Feb; 53(3):1338-46. PubMed ID: 20047331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular dynamics-assisted pharmacophore modeling of caspase-3-isatin sulfonamide complex: Recognizing essential intermolecular contacts and features of sulfonamide inhibitor class for caspase-3 binding.
    Kumar SP; Patel CN; Jha PC; Pandya HA
    Comput Biol Chem; 2017 Dec; 71():117-128. PubMed ID: 29153890
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ligand-Based Pharmacophore Modeling Using Novel 3D Pharmacophore Signatures.
    Kutlushina A; Khakimova A; Madzhidov T; Polishchuk P
    Molecules; 2018 Nov; 23(12):. PubMed ID: 30486389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of 3D-QSAR Model for Acetylcholinesterase Inhibitors Using a Combination of Fingerprint, Molecular Docking, and Structure-Based Pharmacophore Approaches.
    Lee S; Barron MG
    Toxicol Sci; 2015 Nov; 148(1):60-70. PubMed ID: 26202430
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery of a novel acetylcholinesterase inhibitor by structure-based virtual screening techniques.
    Chen Y; Fang L; Peng S; Liao H; Lehmann J; Zhang Y
    Bioorg Med Chem Lett; 2012 May; 22(9):3181-7. PubMed ID: 22472693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Construction of the pharmacophore model of acetylcholinesterase inhibitor.
    Zhu Y; Tong XY; Zhao Y; Chen H; Jiang FC
    Yao Xue Xue Bao; 2008 Mar; 43(3):267-76. PubMed ID: 18630262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Morphinans and isoquinolines: acetylcholinesterase inhibition, pharmacophore modeling, and interaction with opioid receptors.
    Schuster D; Spetea M; Music M; Rief S; Fink M; Kirchmair J; Schütz J; Wolber G; Langer T; Stuppner H; Schmidhammer H; Rollinger JM
    Bioorg Med Chem; 2010 Jul; 18(14):5071-80. PubMed ID: 20580236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery of new selective cytotoxic agents against Bcl-2 expressing cancer cells using ligand-based modeling.
    Aboalhaija NH; Zihlif MA; Taha MO
    Chem Biol Interact; 2016 Apr; 250():12-26. PubMed ID: 26954606
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery of new cholesteryl ester transfer protein inhibitors via ligand-based pharmacophore modeling and QSAR analysis followed by synthetic exploration.
    Abu Khalaf R; Abu Sheikha G; Bustanji Y; Taha MO
    Eur J Med Chem; 2010 Apr; 45(4):1598-617. PubMed ID: 20116902
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of novel HER2 inhibitors against gastric cancer derived from flavonoid source of
    Babu TM; Rammohan A; Baki VB; Devi S; Gunasekar D; Rajendra W
    Drug Des Devel Ther; 2016; 10():3611-3632. PubMed ID: 27853354
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stepwise development of structure-activity relationship of diverse PARP-1 inhibitors through comparative and validated in silico modeling techniques and molecular dynamics simulation.
    Halder AK; Saha A; Saha KD; Jha T
    J Biomol Struct Dyn; 2015; 33(8):1756-79. PubMed ID: 25350685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.